CNBX 10-Q out. Very impressive 10-Q as the company has a lot of drugs on the pipeline to start Phase I/II this year (there is one underway in the 1st qtr of 2024). Plus they made a profit in this qtr compared to a big loss in 2023. 2024 is the year for this company. No changes in outstanding shares. Must be the only company with a tiny 31M float and lots of upside potential. Fireworks are about to begin. CNBX http://archive.fast-edgar.com/20240416/A322M22CZ22HW9Z2222H2ZYZ3LPS8ZK2S262
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.